Impact of COVID-19 Outbreak on Anti-Malarial Drug, Global Market Research Report 2020

Publisher Name :
Date: 01-May-2020
No. of pages: 91
Inquire Before Buying

The global Anti-Malarial Drug market is valued at US$ 682.6 million in 2020 is expected to reach US$ 818.1 million by the end of 2026, growing at a CAGR of 2.6% during 2021-2026.

This report focuses on Anti-Malarial Drug volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Anti-Malarial Drug market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.

Market Segment Analysis

The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Anti-Malarial Drug market is segmented into

- Plasmodium Falciparum

- Plasmodium Vivax

- Plasmodium Malariae

- Plasmodium Ovale

Segment by Application

- Hospital Pharmacy

- Retail Pharmacy

- E-Commerce

- Others

Global Anti-Malarial Drug Market: Regional Analysis

The Anti-Malarial Drug market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Anti-Malarial Drug market report are:

North America

- U.S.

- Canada

Europe

- Germany

- France

- U.K.

- Italy

- Russia

Asia-Pacific

- China

- Japan

- South Korea

- India

- Australia

- Taiwan

- Indonesia

- Thailand

- Malaysia

- Philippines

- Vietnam

Latin America

- Mexico

- Brazil

- Argentina

Middle East & Africa

- Turkey

- Saudi Arabia

- U.A.E

Global Anti-Malarial Drug Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Anti-Malarial Drug market include:

- GlaxoSmithKline

- Ranbaxy

- Zydus Cadila

- Alvizia

- Bayer

- Ipca

- Merck

- F. Hoffmann-La Roche

- Novartis

- Pfizer

Impact of COVID-19 Outbreak on Anti-Malarial Drug, Global Market Research Report 2020

Table of Contents
1 Anti-Malarial Drug Market Overview
1.1 Product Overview and Scope of Anti-Malarial Drug
1.2 Anti-Malarial Drug Segment by Type
1.2.1 Global Anti-Malarial Drug Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Plasmodium Falciparum
1.2.3 Plasmodium Vivax
1.2.4 Plasmodium Malariae
1.2.5 Plasmodium Ovale
1.3 Anti-Malarial Drug Segment by Application
1.3.1 Anti-Malarial Drug Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 E-Commerce
1.3.5 Others
1.4 Global Anti-Malarial Drug Market Size Estimates and Forecasts
1.4.1 Global Anti-Malarial Drug Revenue 2015-2026
1.4.2 Global Anti-Malarial Drug Sales 2015-2026
1.4.3 Anti-Malarial Drug Market Size by Region: 2020 Versus 2026
2 Global Anti-Malarial Drug Market Competition by Manufacturers
2.1 Global Anti-Malarial Drug Sales Market Share by Manufacturers (2015-2020)
2.2 Global Anti-Malarial Drug Revenue Share by Manufacturers (2015-2020)
2.3 Global Anti-Malarial Drug Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Anti-Malarial Drug Manufacturing Sites, Area Served, Product Type
2.5 Anti-Malarial Drug Market Competitive Situation and Trends
2.5.1 Anti-Malarial Drug Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Anti-Malarial Drug Players (Opinion Leaders)
3 Anti-Malarial Drug Retrospective Market Scenario by Region
3.1 Global Anti-Malarial Drug Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Anti-Malarial Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Anti-Malarial Drug Market Facts & Figures by Country
3.3.1 North America Anti-Malarial Drug Sales by Country
3.3.2 North America Anti-Malarial Drug Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Anti-Malarial Drug Market Facts & Figures by Country
3.4.1 Europe Anti-Malarial Drug Sales by Country
3.4.2 Europe Anti-Malarial Drug Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anti-Malarial Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Anti-Malarial Drug Sales by Region
3.5.2 Asia Pacific Anti-Malarial Drug Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Anti-Malarial Drug Market Facts & Figures by Country
3.6.1 Latin America Anti-Malarial Drug Sales by Country
3.6.2 Latin America Anti-Malarial Drug Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Anti-Malarial Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Anti-Malarial Drug Sales by Country
3.7.2 Middle East and Africa Anti-Malarial Drug Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Anti-Malarial Drug Historic Market Analysis by Type
4.1 Global Anti-Malarial Drug Sales Market Share by Type (2015-2020)
4.2 Global Anti-Malarial Drug Revenue Market Share by Type (2015-2020)
4.3 Global Anti-Malarial Drug Price Market Share by Type (2015-2020)
4.4 Global Anti-Malarial Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Anti-Malarial Drug Historic Market Analysis by Application
5.1 Global Anti-Malarial Drug Sales Market Share by Application (2015-2020)
5.2 Global Anti-Malarial Drug Revenue Market Share by Application (2015-2020)
5.3 Global Anti-Malarial Drug Price by Application (2015-2020)
6 Company Profiles and Key Figures in Anti-Malarial Drug Business
6.1 GlaxoSmithKline
6.1.1 Corporation Information
6.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
6.1.3 GlaxoSmithKline Anti-Malarial Drug Sales, Revenue and Gross Margin (2015-2020)
6.1.4 GlaxoSmithKline Products Offered
6.1.5 GlaxoSmithKline Recent Development
6.2 Ranbaxy
6.2.1 Ranbaxy Anti-Malarial Drug Production Sites and Area Served
6.2.2 Ranbaxy Description, Business Overview and Total Revenue
6.2.3 Ranbaxy Anti-Malarial Drug Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Ranbaxy Products Offered
6.2.5 Ranbaxy Recent Development
6.3 Zydus Cadila
6.3.1 Zydus Cadila Anti-Malarial Drug Production Sites and Area Served
6.3.2 Zydus Cadila Description, Business Overview and Total Revenue
6.3.3 Zydus Cadila Anti-Malarial Drug Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Zydus Cadila Products Offered
6.3.5 Zydus Cadila Recent Development
6.4 Alvizia
6.4.1 Alvizia Anti-Malarial Drug Production Sites and Area Served
6.4.2 Alvizia Description, Business Overview and Total Revenue
6.4.3 Alvizia Anti-Malarial Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Alvizia Products Offered
6.4.5 Alvizia Recent Development
6.5 Bayer
6.5.1 Bayer Anti-Malarial Drug Production Sites and Area Served
6.5.2 Bayer Description, Business Overview and Total Revenue
6.5.3 Bayer Anti-Malarial Drug Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Bayer Products Offered
6.5.5 Bayer Recent Development
6.6 Ipca
6.6.1 Ipca Anti-Malarial Drug Production Sites and Area Served
6.6.2 Ipca Description, Business Overview and Total Revenue
6.6.3 Ipca Anti-Malarial Drug Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Ipca Products Offered
6.6.5 Ipca Recent Development
6.7 Merck
6.6.1 Merck Anti-Malarial Drug Production Sites and Area Served
6.6.2 Merck Description, Business Overview and Total Revenue
6.6.3 Merck Anti-Malarial Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Merck Products Offered
6.7.5 Merck Recent Development
6.8 F. Hoffmann-La Roche
6.8.1 F. Hoffmann-La Roche Anti-Malarial Drug Production Sites and Area Served
6.8.2 F. Hoffmann-La Roche Description, Business Overview and Total Revenue
6.8.3 F. Hoffmann-La Roche Anti-Malarial Drug Sales, Revenue and Gross Margin (2015-2020)
6.8.4 F. Hoffmann-La Roche Products Offered
6.8.5 F. Hoffmann-La Roche Recent Development
6.9 Novartis
6.9.1 Novartis Anti-Malarial Drug Production Sites and Area Served
6.9.2 Novartis Description, Business Overview and Total Revenue
6.9.3 Novartis Anti-Malarial Drug Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Novartis Products Offered
6.9.5 Novartis Recent Development
6.10 Pfizer
6.10.1 Pfizer Anti-Malarial Drug Production Sites and Area Served
6.10.2 Pfizer Description, Business Overview and Total Revenue
6.10.3 Pfizer Anti-Malarial Drug Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Pfizer Products Offered
6.10.5 Pfizer Recent Development
7 Anti-Malarial Drug Manufacturing Cost Analysis
7.1 Anti-Malarial Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anti-Malarial Drug
7.4 Anti-Malarial Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Anti-Malarial Drug Distributors List
8.3 Anti-Malarial Drug Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Anti-Malarial Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anti-Malarial Drug by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Anti-Malarial Drug by Type (2021-2026)
10.2 Anti-Malarial Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anti-Malarial Drug by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Anti-Malarial Drug by Application (2021-2026)
10.3 Anti-Malarial Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anti-Malarial Drug by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Anti-Malarial Drug by Region (2021-2026)
10.4 North America Anti-Malarial Drug Estimates and Projections (2021-2026)
10.5 Europe Anti-Malarial Drug Estimates and Projections (2021-2026)
10.6 Asia Pacific Anti-Malarial Drug Estimates and Projections (2021-2026)
10.7 Latin America Anti-Malarial Drug Estimates and Projections (2021-2026)
10.8 Middle East and Africa Anti-Malarial Drug Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Anti-Malarial Drug Sales (MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Anti-Malarial Drug Sales (MT) Comparison by Application: 2020 VS 2026
Table 3. Global Anti-Malarial Drug Market Size by Type (MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Anti-Malarial Drug Manufacturers Covered in This Study
Table 5. Global Anti-Malarial Drug Sales (MT) by Manufacturers (2015-2020)
Table 6. Global Anti-Malarial Drug Sales Share by Manufacturers (2015-2020)
Table 7. Global Anti-Malarial Drug Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Anti-Malarial Drug Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Anti-Malarial Drug Average Price (USD/Kg) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Anti-Malarial Drug Sales Sites and Area Served
Table 11. Manufacturers Anti-Malarial Drug Product Types
Table 12. Global Anti-Malarial Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Anti-Malarial Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Malarial Drug as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Anti-Malarial Drug Players
Table 16. Global Anti-Malarial Drug Sales (MT) by Region (2015-2020)
Table 17. Global Anti-Malarial Drug Sales Market Share by Region (2015-2020)
Table 18. Global Anti-Malarial Drug Revenue (Million US$) by Region (2015-2020)
Table 19. Global Anti-Malarial Drug Revenue Market Share by Region (2015-2020)
Table 20. North America Anti-Malarial Drug Sales by Country (2015-2020) (MT)
Table 21. North America Anti-Malarial Drug Sales Market Share by Country (2015-2020)
Table 22. North America Anti-Malarial Drug Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Anti-Malarial Drug Revenue Market Share by Country (2015-2020)
Table 24. Europe Anti-Malarial Drug Sales by Country (2015-2020) (MT)
Table 25. Europe Anti-Malarial Drug Sales Market Share by Country (2015-2020)
Table 26. Europe Anti-Malarial Drug Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Anti-Malarial Drug Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Anti-Malarial Drug Sales by Region (2015-2020) (MT)
Table 29. Asia Pacific Anti-Malarial Drug Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Anti-Malarial Drug Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Anti-Malarial Drug Revenue Market Share by Region (2015-2020)
Table 32. Latin America Anti-Malarial Drug Sales by Country (2015-2020) (MT)
Table 33. Latin America Anti-Malarial Drug Sales Market Share by Country (2015-2020)
Table 34. Latin America Anti-Malarial Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Anti-Malarial Drug Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Anti-Malarial Drug Sales by Country (2015-2020) (MT)
Table 37. Middle East and Africa Anti-Malarial Drug Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Anti-Malarial Drug Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Anti-Malarial Drug Revenue Market Share by Country (2015-2020)
Table 40. Global Anti-Malarial Drug Sales (MT) by Type (2015-2020)
Table 41. Global Anti-Malarial Drug Sales Share by Type (2015-2020)
Table 42. Global Anti-Malarial Drug Revenue (Million US$) by Type (2015-2020)
Table 43. Global Anti-Malarial Drug Revenue Share by Type (2015-2020)
Table 44. Global Anti-Malarial Drug Price (USD/Kg) by Type (2015-2020)
Table 45. Global Anti-Malarial Drug Sales (MT) by Application (2015-2020)
Table 46. Global Anti-Malarial Drug Sales Market Share by Application (2015-2020)
Table 47. Global Anti-Malarial Drug Sales Growth Rate by Application (2015-2020)
Table 48. GlaxoSmithKline Anti-Malarial Drug Corporation Information
Table 49. GlaxoSmithKline Description and Business Overview
Table 50. GlaxoSmithKline Anti-Malarial Drug Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 51. GlaxoSmithKline Main Product
Table 52. GlaxoSmithKline Recent Development
Table 53. Ranbaxy Anti-Malarial Drug Corporation Information
Table 54. Ranbaxy Corporation Information
Table 55. Ranbaxy Anti-Malarial Drug Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 56. Ranbaxy Main Product
Table 57. Ranbaxy Recent Development
Table 58. Zydus Cadila Anti-Malarial Drug Corporation Information
Table 59. Zydus Cadila Corporation Information
Table 60. Zydus Cadila Anti-Malarial Drug Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 61. Zydus Cadila Main Product
Table 62. Zydus Cadila Recent Development
Table 63. Alvizia Anti-Malarial Drug Corporation Information
Table 64. Alvizia Corporation Information
Table 65. Alvizia Anti-Malarial Drug Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 66. Alvizia Main Product
Table 67. Alvizia Recent Development
Table 68. Bayer Anti-Malarial Drug Corporation Information
Table 69. Bayer Corporation Information
Table 70. Bayer Anti-Malarial Drug Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 71. Bayer Main Product
Table 72. Bayer Recent Development
Table 73. Ipca Anti-Malarial Drug Corporation Information
Table 74. Ipca Corporation Information
Table 75. Ipca Anti-Malarial Drug Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 76. Ipca Main Product
Table 77. Ipca Recent Development
Table 78. Merck Anti-Malarial Drug Corporation Information
Table 79. Merck Corporation Information
Table 80. Merck Anti-Malarial Drug Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 81. Merck Main Product
Table 82. Merck Recent Development
Table 83. F. Hoffmann-La Roche Anti-Malarial Drug Corporation Information
Table 84. F. Hoffmann-La Roche Corporation Information
Table 85. F. Hoffmann-La Roche Anti-Malarial Drug Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 86. F. Hoffmann-La Roche Main Product
Table 87. F. Hoffmann-La Roche Recent Development
Table 88. Novartis Anti-Malarial Drug Corporation Information
Table 89. Novartis Corporation Information
Table 90. Novartis Anti-Malarial Drug Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 91. Novartis Main Product
Table 92. Novartis Recent Development
Table 93. Pfizer Anti-Malarial Drug Corporation Information
Table 94. Pfizer Corporation Information
Table 95. Pfizer Anti-Malarial Drug Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 96. Pfizer Main Product
Table 97. Pfizer Recent Development
Table 98. Sales Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Anti-Malarial Drug Distributors List
Table 101. Anti-Malarial Drug Customers List
Table 102. Market Key Trends
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Global Anti-Malarial Drug Sales (MT) Forecast by Type (2021-2026)
Table 106. Global Anti-Malarial Drug Sales Market Share Forecast by Type (2021-2026)
Table 107. Global Anti-Malarial Drug Revenue (Million US$) Forecast by Type (2021-2026)
Table 108. Global Anti-Malarial Drug Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 109. Global Anti-Malarial Drug Sales (MT) Forecast by Application (2021-2026)
Table 110. Global Anti-Malarial Drug Revenue (Million US$) Forecast by Application (2021-2026)
Table 111. Global Anti-Malarial Drug Sales (MT) Forecast by Region (2021-2026)
Table 112. Global Anti-Malarial Drug Sales Market Share Forecast by Region (2021-2026)
Table 113. Global Anti-Malarial Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Global Anti-Malarial Drug Revenue Market Share Forecast by Region (2021-2026)
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Anti-Malarial Drug
Figure 2. Global Anti-Malarial Drug Sales Market Share by Type: 2020 VS 2026
Figure 3. Plasmodium Falciparum Product Picture
Figure 4. Plasmodium Vivax Product Picture
Figure 5. Plasmodium Malariae Product Picture
Figure 6. Plasmodium Ovale Product Picture
Figure 7. Global Anti-Malarial Drug Consumption Market Share by Application: 2020 VS 2026
Figure 8. Hospital Pharmacy
Figure 9. Retail Pharmacy
Figure 10. E-Commerce
Figure 11. Others
Figure 12. Global Anti-Malarial Drug Market Size 2015-2026 (US$ Million)
Figure 13. Global Anti-Malarial Drug Sales Capacity (MT) (2015-2026)
Figure 14. Global Anti-Malarial Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Anti-Malarial Drug Sales Share by Manufacturers in 2020
Figure 16. Global Anti-Malarial Drug Revenue Share by Manufacturers in 2019
Figure 17. The Global 5 and 10 Largest Players: Market Share by Anti-Malarial Drug Revenue in 2019
Figure 18. Anti-Malarial Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Anti-Malarial Drug Sales Market Share by Region (2015-2020)
Figure 20. Global Anti-Malarial Drug Sales Market Share by Region in 2019
Figure 21. Global Anti-Malarial Drug Revenue Market Share by Region (2015-2020)
Figure 22. Global Anti-Malarial Drug Revenue Market Share by Region in 2019
Figure 23. North America Anti-Malarial Drug Sales Market Share by Country in 2019
Figure 24. North America Anti-Malarial Drug Revenue Market Share by Country in 2019
Figure 25. U.S. Anti-Malarial Drug Sales Growth Rate (2015-2020) (MT)
Figure 26. U.S. Anti-Malarial Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Canada Anti-Malarial Drug Sales Growth Rate (2015-2020) (MT)
Figure 28. Canada Anti-Malarial Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. Europe Anti-Malarial Drug Sales Market Share by Country in 2019
Figure 30. Europe Anti-Malarial Drug Revenue Market Share by Country in 2019
Figure 31. Germany Anti-Malarial Drug Sales Growth Rate (2015-2020) (MT)
Figure 32. Germany Anti-Malarial Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. France Anti-Malarial Drug Sales Growth Rate (2015-2020) (MT)
Figure 34. France Anti-Malarial Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. U.K. Anti-Malarial Drug Sales Growth Rate (2015-2020) (MT)
Figure 36. U.K. Anti-Malarial Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Italy Anti-Malarial Drug Sales Growth Rate (2015-2020) (MT)
Figure 38. Italy Anti-Malarial Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Russia Anti-Malarial Drug Sales Growth Rate (2015-2020) (MT)
Figure 40. Russia Anti-Malarial Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Asia Pacific Anti-Malarial Drug Sales Market Share by Region in 2019
Figure 42. Asia Pacific Anti-Malarial Drug Revenue Market Share by Region in 2019
Figure 43. China Anti-Malarial Drug Sales Growth Rate (2015-2020) (MT)
Figure 44. China Anti-Malarial Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Japan Anti-Malarial Drug Sales Growth Rate (2015-2020) (MT)
Figure 46. Japan Anti-Malarial Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. South Korea Anti-Malarial Drug Sales Growth Rate (2015-2020) (MT)
Figure 48. South Korea Anti-Malarial Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. India Anti-Malarial Drug Sales Growth Rate (2015-2020) (MT)
Figure 50. India Anti-Malarial Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Australia Anti-Malarial Drug Sales Growth Rate (2015-2020) (MT)
Figure 52. Australia Anti-Malarial Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Taiwan Anti-Malarial Drug Sales Growth Rate (2015-2020) (MT)
Figure 54. Taiwan Anti-Malarial Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Indonesia Anti-Malarial Drug Sales Growth Rate (2015-2020) (MT)
Figure 56. Indonesia Anti-Malarial Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Thailand Anti-Malarial Drug Sales Growth Rate (2015-2020) (MT)
Figure 58. Thailand Anti-Malarial Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Malaysia Anti-Malarial Drug Sales Growth Rate (2015-2020) (MT)
Figure 60. Malaysia Anti-Malarial Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Philippines Anti-Malarial Drug Sales Growth Rate (2015-2020) (MT)
Figure 62. Philippines Anti-Malarial Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Vietnam Anti-Malarial Drug Sales Growth Rate (2015-2020) (MT)
Figure 64. Vietnam Anti-Malarial Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Latin America Anti-Malarial Drug Sales Market Share by Country in 2019
Figure 66. Latin America Anti-Malarial Drug Revenue Market Share by Country in 2019
Figure 67. Mexico Anti-Malarial Drug Sales Growth Rate (2015-2020) (MT)
Figure 68. Mexico Anti-Malarial Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Brazil Anti-Malarial Drug Sales Growth Rate (2015-2020) (MT)
Figure 70. Brazil Anti-Malarial Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Argentina Anti-Malarial Drug Sales Growth Rate (2015-2020) (MT)
Figure 72. Argentina Anti-Malarial Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Middle East and Africa Anti-Malarial Drug Sales Market Share by Country in 2019
Figure 74. Middle East and Africa Anti-Malarial Drug Revenue Market Share by Country in 2019
Figure 75. Turkey Anti-Malarial Drug Sales Growth Rate (2015-2020) (MT)
Figure 76. Turkey Anti-Malarial Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Saudi Arabia Anti-Malarial Drug Sales Growth Rate (2015-2020) (MT)
Figure 78. Saudi Arabia Anti-Malarial Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. U.A.E Anti-Malarial Drug Sales Growth Rate (2015-2020) (MT)
Figure 80. U.A.E Anti-Malarial Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Sales Market Share of Anti-Malarial Drug by Type (2015-2020)
Figure 82. Sales Market Share of Anti-Malarial Drug by Type in 2019
Figure 83. Revenue Share of Anti-Malarial Drug by Type (2015-2020)
Figure 84. Revenue Market Share of Anti-Malarial Drug by Type in 2019
Figure 85. Global Anti-Malarial Drug Sales Growth by Type (2015-2020) (MT)
Figure 86. Global Anti-Malarial Drug Sales Market Share by Application (2015-2020)
Figure 87. Global Anti-Malarial Drug Sales Market Share by Application in 2019
Figure 88. Global Revenue Share of Anti-Malarial Drug by Application (2015-2020)
Figure 89. Global Revenue Share of Anti-Malarial Drug by Application in 2020
Figure 90. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Ranbaxy Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Zydus Cadila Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Alvizia Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Ipca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Price Trend of Key Raw Materials
Figure 101. Manufacturing Cost Structure of Anti-Malarial Drug
Figure 102. Manufacturing Process Analysis of Anti-Malarial Drug
Figure 103. Anti-Malarial Drug Industrial Chain Analysis
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Figure 106. Porter's Five Forces Analysis
Figure 107. North America Anti-Malarial Drug Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 108. North America Anti-Malarial Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Europe Anti-Malarial Drug Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 110. Europe Anti-Malarial Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Latin America Anti-Malarial Drug Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 112. Latin America Anti-Malarial Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Middle East and Africa Anti-Malarial Drug Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 114. Middle East and Africa Anti-Malarial Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Asia Pacific Anti-Malarial Drug Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 116. Asia Pacific Anti-Malarial Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Bottom-up and Top-down Approaches for This Report
Figure 118. Data Triangulation
Figure 119. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs